Inflammatory bowel disease, Internal medicine, Ulcerative colitis, Immunology and Disease are his primary areas of study. His Inflammatory bowel disease research is multidisciplinary, incorporating perspectives in Young adult, Concomitant, Genetic linkage and Metagenomics. His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology and Surgery.
His work carried out in the field of Ulcerative colitis brings together such families of science as Colitis, Retrospective cohort study, Intensive care medicine, Age of onset and Pediatrics. He has researched Immunology in several fields, including Genetics and Genome-wide association study. His Disease research incorporates elements of Parenteral nutrition, Abdominal pain, Case-control study and Diarrhea.
The scientist’s investigation covers issues in Internal medicine, Inflammatory bowel disease, Gastroenterology, Ulcerative colitis and Crohn's disease. Internal medicine and Surgery are frequently intertwined in his study. His study on Inflammatory bowel disease also encompasses disciplines like
His Gastroenterology study combines topics from a wide range of disciplines, such as Crohn disease and Biopsy, Prospective cohort study, Pathology. The concepts of his Ulcerative colitis study are interwoven with issues in El Niño, Colitis and Cohort. Robert N. Baldassano studied Disease and Genome-wide association study that intersect with Genetic association.
His scientific interests lie mostly in Internal medicine, Gastroenterology, Inflammatory bowel disease, Immunology and Ulcerative colitis. His work is dedicated to discovering how Gastroenterology, Area under the curve are connected with Confidence interval and other disciplines. His Inflammatory bowel disease study necessitates a more in-depth grasp of Disease.
His research investigates the connection between Disease and topics such as Genome-wide association study that intersect with problems in Genetic association. His research in Immunology focuses on subjects like Microbiome, which are connected to Feces. His Ulcerative colitis research focuses on Newly diagnosed and how it relates to Surgery.
His primary scientific interests are in Internal medicine, Inflammatory bowel disease, Immunology, Crohn's disease and Gastroenterology. His research integrates issues of Tumor necrosis factor alpha, RAR-related orphan receptor gamma and Single-nucleotide polymorphism, Genome-wide association study in his study of Inflammatory bowel disease. His Immunology study combines topics in areas such as NADPH oxidase and Disease.
His studies deal with areas such as Microbiome, Adalimumab, Surgery, Chronic granulomatous disease and Case-control study as well as Crohn's disease. His studies in Gastroenterology integrate themes in fields like Gene expression, In situ hybridization, Retrospective cohort study, Complication and Severity of illness. His work on Crypt Abscess as part of his general Ulcerative colitis study is frequently connected to Plasmacytosis, thereby bridging the divide between different branches of science.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Human gut microbiome viewed across age and geography
Tanya Yatsunenko;Federico E Rey;Mark J Manary;Mark J Manary;Indi Trehan;Indi Trehan.
Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes
Gary D. Wu;Jun Chen;Christian Hoffmann;Christian Hoffmann;Kyle Bittinger.
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
Andre Franke;Dermot P B McGovern;Jeffrey C. Barrett;Kai Wang.
Nature Genetics (2010)
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
Dirk Gevers;Subra Kugathasan;Lee A. Denson;Yoshiki Vázquez-Baeza.
Cell Host & Microbe (2014)
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47.
Carl A. Anderson;Gabrielle Boucher;Charlie W. Lees;Andre Franke.
Nature Genetics (2011)
Induction and Maintenance Infliximab Therapy for the Treatment of Moderate-to-Severe Crohn’s Disease in Children
Jeffrey Hyams;Wallace Crandall;Subra Kugathasan;Anne Griffiths.
Inflammation, Antibiotics, and Diet as Environmental Stressors of the Gut Microbiome in Pediatric Crohn's Disease.
James D. Lewis;Eric Z. Chen;Robert N. Baldassano;Anthony R. Otley.
Cell Host & Microbe (2015)
Correlation between intraluminal oxygen gradient and radial partitioning of intestinal microbiota.
Lindsey Albenberg;Tatiana V. Esipova;Colleen P. Judge;Kyle Bittinger.
Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry.
Melvin B. Heyman;Barbara S. Kirschner;Benjamin D. Gold;George Ferry.
The Journal of Pediatrics (2005)
Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis.
Erasmo Miele;Filomena Pascarella;Eleonora Giannetti;Lucia Quaglietta.
The American Journal of Gastroenterology (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: